A Safety, Tolerability and Pharmacokinetics Study of TransCon Treprostinil in Healthy Adult Male Volunteers
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To determine the maximum tolerated dose (MTD) and assess safety and tolerability of
escalating single doses of TransCon PEG treprostinil administered as a subcutaneous injection
to healthy male volunteers.